PCN127 What Is the IMPACT of the Introduction of Ipilimumab, Pembrolizumab, and Nivolumab on Malignant Melanoma in Nordics?

Abstract

Authors

G. Mangat S. Sharma

Full Text Cite This Article
Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×